Coeptis Therapeutics Holdings, Inc. and Z Squared Inc., a Dogecoin mining company, announced on April 25, 2025, they have entered into a definitive merger agreement. This business combination will result in Z Squared becoming a wholly-owned subsidiary of Coeptis. The Boards of Directors of both companies have approved the proposed merger, which is subject to customary closing conditions.
Under the terms of the agreement, holders of outstanding Z Squared shares will receive equity in Coeptis in exchange for 9,000 U.S.-based Dogecoin mining machines at closing. In connection with the merger, Coeptis intends to spin out its biopharmaceutical operations, which will continue to operate separately from Coeptis after the merger. The technology operations will remain within the company.
The transaction is anticipated to close in the third quarter of 2025, assuming all conditions are satisfied. It is anticipated that Coeptis will be rebranded and operate as Z Squared, Inc., and is expected to list on the Nasdaq Capital Market. The combined company will focus on advancing Z Squared’s digital asset mining expertise, primarily generating Dogecoin (DOGE).
The surviving entity will be led by Z Squared executives, with David Halabu as Chief Executive Officer and Michelle Burke as Chief Operating Officer. Current Coeptis President and Chief Executive Officer, Dave Mehalick, will exit from the Board of Directors upon closing. David Halabu stated the goal is to create the largest publicly-traded company in the United States primarily focused on DOGE mining.
Dave Mehalick expressed excitement about bringing this opportunity to shareholders to become involved in the Dogecoin market space. He also noted the ability to remain involved in biopharmaceutical operations due to the contemplated spin-out. This merger represents a dramatic strategic pivot for Coeptis, shifting its primary focus from biopharmaceuticals to the highly volatile cryptocurrency mining industry.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.